Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

被引:8
作者
Su, Jun [1 ]
Bylsma, Lauren C. [2 ]
Jiang, Xiaohui [2 ]
Morales Arias, Jaime [1 ]
Jain, Nisha [1 ]
Nordyke, Robert J. [3 ]
机构
[1] Sanofi, 50 Binney St, Cambridge, MA 02142 USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] Beta6 Consulting Grp, Los Angeles, CA USA
关键词
Disease burden; healthcare resource utilization; cold agglutinin disease; autoimmune hemolytic anemia; database analysis; BURDEN; ANEMIA; COSTS;
D O I
10.1080/13696998.2020.1764006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of patients with CAD with a matched non-CAD cohort in the United States. Materials and methods: Patients with CAD were identified from 2006 to 2016 in the Optum-Humedica database using CAD terms in clinical notes and hematologist review. Patients were required to have Integrated Delivery Network records and >= 6 months' follow-up before and after the first CAD mention date (index date). Patients with CAD were matched to a non-CAD cohort based on demographics. Multivariate analyses assessed inpatient hospitalizations, outpatient visits, emergency room visits, and transfusion use between cohorts 6 months before and 12 months after the index date. Results: Of 814 patients with CAD, 410 met inclusion criteria and were matched to 3,390 patients without CAD. Mean age of patients with CAD was 68.0 years; approximately 62% were female. In the 12 months after the index date, mean inpatient hospitalizations (0.83 vs. 0.25), outpatient visits (17.26 vs. 6.77), emergency room visits (0.55 vs. 0.32), and transfusion days (1.05 vs. 0.05) were higher for patients with CAD than the matched non-CAD cohort (all p < .0001). Similarly, in the 6 months before the index date, patients with CAD had higher HRU than matched patients without CAD for all measures evaluated. Limitations: Results of this study are based on patient information from the Optum-Humedica database, which is limited to commercially insured patients and may not represent the overall CAD population. Conclusions: CAD places a substantial burden on patients and healthcare systems. In addition, the high HRU for patients with CAD observed in the 6 months before diagnosis indicates that disease awareness and better diagnostic practices may be needed.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 50 条
  • [21] Real-world assessment of "OFF" episode-related healthcare resource utilization among patients with Parkinson's disease in the United States
    Thach, Andrew
    Jones, Eddie
    Pappert, Eric
    Pike, James
    Wright, Jack
    Gillespie, Alexander
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 540 - 549
  • [22] Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States
    Nalamachu, Sri
    Robinson, Rebecca L.
    Viktrup, Lars
    Cappelleri, Joseph C.
    Bushmakin, Andrew G.
    Tive, Leslie
    Mellor, Jennifer
    Hatchell, Niall
    Jackson, James
    POSTGRADUATE MEDICINE, 2021, 133 (01) : 10 - 19
  • [23] Healthcare resource utilization and costs among children with cystic fibrosis in the United States
    Thorat, Teja
    McGarry, Lisa J.
    Bonafede, Machaon M.
    Limone, Brendan L.
    Rubin, Jaime L.
    Jariwala-Parikh, Krutika
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2021, 56 (09) : 2833 - 2844
  • [24] Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States
    Fishman, Jesse
    Martin, Melinda
    Labiner, David M.
    Lew, Carolyn R.
    Johnson, Barbara H.
    EPILEPSY & BEHAVIOR, 2019, 99
  • [25] A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States
    Krasenbaum, Lynda J.
    HEADACHE, 2017, 57 (09): : 1451 - 1452
  • [26] Healthcare resource utilization, treatment patterns, and cost of care among patients with thermal burns and inpatient autografting in two large privately insured populations in the United States
    Yu, Tzy-Chyi
    Zhang, Xian
    Smiell, Janice
    Zhou, Huanxue
    Tan, Ruixin
    Boing, Elaine
    Tan, Hiangkiat
    BURNS, 2020, 46 (04) : 825 - 835
  • [27] Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States
    Eby, Elizabeth L.
    Van Brunt, Kate
    Brusko, Cynthia
    Curtis, Bradley
    Lage, Maureen J.
    CLINICAL THERAPEUTICS, 2015, 37 (10) : 2297 - 2308
  • [28] Healthcare utilization and cost of pneumococcal disease in the United States
    Huang, Susan S.
    Johnson, Kristen M.
    Ray, G. Thomas
    Wroe, Peter
    Lieu, Tracy A.
    Moore, Matthew R.
    Zell, Elizabeth R.
    Linder, Jeffrey A.
    Grijalva, Carlos G.
    Metlay, Joshua P.
    Finkelstein, Jonathan A.
    VACCINE, 2011, 29 (18) : 3398 - 3412
  • [29] Economic Burden of HIV in a Commercially Insured Population in the United States
    Chen, Cindy Y.
    Donga, Prina
    Campbell, Alicia K.
    Taiwo, Babafemi
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (01): : 10 - 19
  • [30] Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States
    Copher, Ronda
    Kee, Arianna
    Gerds, Aaron
    ONCOLOGIST, 2022, 27 (03) : 228 - 235